Trailing-twelve-month (TTM) revenue is $443.31 Million with a year-over-year growth of (10.09%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $121,594,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q4 FY2025Period ended 2025-12-31 | $122,774,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-27 |
| Q1 FY2026Period ended 2026-03-31 | $118,308,999 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $80,635,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $443,311,999 |
Current P/S: $1,394,366,575 market capitalization ÷ $443,311,999 TTM revenue = 3.15x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $80.64M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:45:57.372Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|
| Advisory Fees | $2M | $2M | $3M |
| Debit Card | $4M | $9M | N/A |
| Fiduciary and Trust | $5M | $8M | $10M |
| Service, Other | $7M | $16M | $8M |
$443.31M
$443.31 Million
(10.09%)
vs. $493.06M a year ago (TTM)
+30.19%
5 Year compound annual growth rate
1 Year
(10.09%)
3 Year
+43.60%
5 Year
+30.19%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $491.11M | +$94.18M | +23.73% |
| 2024 | $396.93M | +$234.65M | +144.59% |
| 2023 | $162.28M | +$34.81M | +27.30% |
| 2022 | $127.48M | +$8.34M | +7.00% |
| 2021 | $119.13M | ($2.24M) | (1.85%) |
| 2020 |
TTM Growth
(10.09%)
3-Year CAGR
+43.60%
5-Year CAGR
+30.19%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 26 comparable quarters.
| Trust Fees |
|---|
| $3M |
| $5M |
| $6M |
| $121.37M |
| ($6.16M) |
| (4.83%) |
